MedPath

The DAPE study: the impact of dementia advisors on the quality of life of dementia sufferers

Completed
Conditions
Dementia
Mental and Behavioural Disorders
Unspecified dementia
Registration Number
ISRCTN33790007
Lead Sponsor
King's College London (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
700
Inclusion Criteria

1. Individuals with a diagnosis of dementia made by their primary care physician or a specialist clinician (no age range although most participants will be over 60 years, either sex)
2. Individuals referred for a specialist assessment with a likely diagnosis of dementia
3. Individuals referred to the Dementia Advisor Programme

Exclusion Criteria

1. Individuals who do not have significant cognitive impairment
2. Individuals with a diagnosis of mild cognitive impairment given by either their primary care physician or specialist clinician
3. Individuals who are not likely to receive a diagnosis of dementia within the next 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dementia Quality of Life (DEMQOL), which is considered the most sensitive measure currently available to measure quality of life in people with dementia. Assessments will be done at baseline and 12 months.
Secondary Outcome Measures
NameTimeMethod
Assessments will be done at baseline and 12 months:<br>1. The Quality of Life in Alzheimer's Disease (QOL-AD)<br>2. The Cornell Scale for Depression in Dementia (CSDD)<br>3. General Health Questionnaire-12 (GHQ-12)<br>4. Service Use and Cost Effectiveness: Modified Client Service Receipt Inventory
© Copyright 2025. All Rights Reserved by MedPath